Department of Cardiovascular Surgery, The First Affiliated Hospital of Soochow University, Soochow, Jiangsu, China.
PLoS One. 2013 Aug 1;8(8):e68837. doi: 10.1371/journal.pone.0068837. Print 2013.
The Wilms' tumor suppressor gene (WT1) has been identified as an oncogene in many malignant diseases such as leukaemia, breast cancer, mesothelioma and lung cancer. However, the role of WT1 in non-small-cell lung cancer (NSCLC) carcinogenesis remains unclear. In this study, we compared WT1 mRNA levels in NSCLC tissues with paired corresponding adjacent tissues and identified significantly higher expression in NSCLC specimens. Cell proliferation of three NSCLC cell lines positively correlated with WT1 expression; moreover, these associations were identified in both cell lines and a xenograft mouse model. Furthermore, we demonstrated that up-regulation of Cyclin D1 and the phosphorylated retinoblastoma protein (p-pRb) was mechanistically related to WT1 accelerating cells to S-phase. In conclusion, our findings demonstrated that WT1 is an oncogene and promotes NSCLC cell proliferation by up-regulating Cyclin D1 and p-pRb expression.
Wilms 肿瘤抑制基因(WT1)已被确定为白血病、乳腺癌、间皮瘤和肺癌等许多恶性疾病的致癌基因。然而,WT1 在非小细胞肺癌(NSCLC)发生中的作用尚不清楚。在这项研究中,我们比较了 NSCLC 组织和配对相应的相邻组织中的 WT1 mRNA 水平,发现 NSCLC 标本中的表达明显更高。三种 NSCLC 细胞系的细胞增殖与 WT1 表达呈正相关;此外,这些关联在细胞系和异种移植小鼠模型中均得到了证实。此外,我们证明了细胞周期蛋白 D1 和磷酸化视网膜母细胞瘤蛋白(p-pRb)的上调与 WT1 加速细胞进入 S 期有关。总之,我们的研究结果表明 WT1 是一种致癌基因,通过上调细胞周期蛋白 D1 和 p-pRb 的表达促进 NSCLC 细胞的增殖。